semaglutide patent protection China's weight-loss drug makers take on global giants as Novo Nordisk expires Novo Nordisk is losing Canadian

Liu Y., Hu Y., and Liu T., Recent Advances in NonPeptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects, Current Medicinal Chemistry 19, no

Effect of kynurenic acid on pupae viability of drosophila melanogaster cinnabar and cardinal eye color mutants with altered tryptophan-kynurenine metabolism

Read More Key Insights Many drug candidates have failed to treat Alzheimers disease, and even the recently approved amyloid-targeting antibodies offer minimal delay in the progression of the condition

The table below shows results from the main semaglutide trials

That difference is what drives the cardiovascular concern about using both

Preclinical and human evidence indicate that KD may improve mitochondrial function, calm mood, and delay neurodegeneration (Jain and Vohora, 2025)